絞り込み

16638

広告

日本人のオピオイド誘発性便秘の頻度は? (日経BP)

癌の疼痛管理など、実臨床でオピオイドを使う機会はとても多いですが、副作用で気になるのは便秘です。どのくらいの患者さんがオピオイド誘発性便秘(OIC)で苦しんでい...

  1. ディフェリンとベピオがじわりシェア伸長 ...
  2. 過去5年、世界は最も暑く (デイリースポ...
  3. 日本初のノーベル賞 湯川秀樹博士の写真2...
  4. 「美しい演説ではなく具体的な計画を」気候...

ニュース一覧

The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.

著者 Ge Y , Chi Y , Min X , Zhao K , Wu B , Wu T , Zhu X , Shi Z , Zhu F , Cui L
Virology.2019 Aug 06 ; 536():58-67.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (6view , 0users)

Full Text Sources

Human infection with H7N9 virus has provoked global public health concern due to the substantial morbidity and mortality. Neuraminidase inhibitors (NAIs) are used as first-line drugs to treat the infection. However, virus quasispecies can evolve rapidly under drug pressure, which may alter various biological characteristics of virus. Using an in vitro evolution platform and next-generation sequencing, we found the presence of peramivir led to changes to the dominant populations of the virus. Two important amino acid substitutions were identified in NA, I222T and H274Y, which caused reduced susceptibilities to oseltamivir or both oseltamivir and peramivir as confirmed by enzyme- and cell-based assays. The NA-H274Y variant showed decreased replicative fitness at the early stage of infection accompanied with impaired NA function. The quasispecies evolution of H7N9 virus and the potential emergence of these two variants should be closely monitored, which may guide the adjustment of antiviral strategies.
PMID: 31400550 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード